Cross-sectional Study of Anorectal Function and Quality of Life in Patients With Middle and Low Rectal Cancer
1 other identifier
observational
600
1 country
1
Brief Summary
Understanding the quality of life and anorectal function changes in patients with middle and low rectal cancer after surgery can guide patients to recover after surgery and provide a valuable reference for surgeons in the selection of surgical methods. The purpose of this study is to: (1) Investigate the complication rate, recurrence and metastasis rate and survival of patients with middle and low rectal cancer. (2) QLQ-C30 and QLQ-CR29 questionnaires were used to assess the quality of life of patients with low- and middle-level rectal cancer at different periods after surgery. (3) Wexner constipation score and LARS syndrome score for anorectal function after operation for low rectal cancer. (4) The CIPE ejaculatory function score, IIEF-5 International Erectile Function Score, and FSFI-6 Female Sexual Function Index were used to assess the changes in sexual function of patients with low- and middle-position rectal cancer after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 26, 2020
CompletedFirst Submitted
Initial submission to the registry
January 1, 2021
CompletedFirst Posted
Study publicly available on registry
January 6, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 28, 2021
CompletedApril 8, 2021
April 1, 2021
4 months
January 1, 2021
April 6, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Overall survival
defined as time from the date of sugery to death
five years after the operation
Secondary Outcomes (7)
QLQ-C30
Every three months after the operation
QLQ-CR29
Every three months after the operation
Wexner
Every three months after the operation
LARS
Every three months after the operation
IIEF-5
Every three months after the operation
- +2 more secondary outcomes
Study Arms (1)
Middle and low rectal cancer
Interventions
Eligibility Criteria
Postoperative patients with middle and low rectal cancer
You may qualify if:
- Postoperative patients with middle rectal cancer
- Postoperative patients with low rectal cancer
You may not qualify if:
- (1)Patients refused to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Quan Wanglead
Study Sites (1)
Jilin University First Hospital
Changchun, Jilin, 130021, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 1, 2021
First Posted
January 6, 2021
Study Start
October 26, 2020
Primary Completion
February 28, 2021
Study Completion
March 28, 2021
Last Updated
April 8, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share